Stocks and Finance

Incyte

Incyte 12/5/2011

10:45 : Incyte ([[INCY]] -2.8%) trades lower after Citi cuts the shares the shares - Incyte (INCY -2.8%) trades lower after Citi cuts the shares the shares to Neutral from Buy. Citi cites limited market potential for Jakafi after conducting a survey that showed only 35% of physicians were expected to prescribe the drug to ...
Source : seekingalpha-com

Incyte 11/16/2011

16:28 : Incyte Stock Surges on Drug Announcement - Incyte stock prices soared after the pharmaceutical company announced that U.S. federal regulators approved a drug meant to treat patients with the rare bone marrow disease myelofibrosis.
Source : ibtimes-com
12:27 : Incyte myelofibrosis drug OK'd by FDA - CHICAGO (MarketWatch) -- The U.S. Food and Drug Administration on Wednesday approved Jakafi (ruxolitinib), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis. Jakafi is manufactured by Incyte ...
Source : marketwatch-com
actualidad Incyte -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts